Abstract

Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2017 - Volume 21, Number 6

Page(s): 495

Download in electronic PDF format for $75
  • Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel Page 1

Abstract

A formulation for preparing Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • promethazine hydrochloride
  • nausea
  • vomiting
  • emesis
  • antiemetic agent
  • topical preparation
  • antihistaminic
  • phenothiazine derivative

Related Categories

  • EAR NOSE THROAT
  • FORMULATIONS
  • GASTROENTEROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2017
Pg. 495
Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2000
Pg. 299
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 391
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 163
Promethazine Hydrochloride 50-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 242-246
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2008
Pg. 267
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2024
Pg. 314
Promethazine Hydrochloride 50 mg/mL in PLO Gel
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2009
Pg. 220-221
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Author(s): Muller George
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
May/Jun 2008
Pg. 270-273
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Author(s): Bassani August S, Banov Daniel, Lehman Paul A
May/Jun 2003
Pg. 180-183
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 392
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 238-241
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A
Jul/Aug 2011
Pg. 308-315
Transdermals: The Skin as Part of a Drug Delivery System
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 168-175
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2006
Pg. 95-98
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Author(s): Moon Richard B